Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000258.3(MYL3):c.*205C>A	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000345567	3	46899400	3	46857910	345567	291660	rs886058581	NC_000003.12:46857909:G:T
NM_000258.3(MYL3):c.*140C>T	MYL3		Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900472	3	46899465	3	46857975	900472	889125	rs764865767	NC_000003.12:46857974:G:A
NM_000258.3(MYL3):c.*112C>A	MYL3		Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Aug 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000900473	3	46899493	3	46858003	900473	889126	rs546968708	NC_000003.12:46858002:G:T
NM_000258.3(MYL3):c.*13G>A	MYL3		Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001809684	3	46899721	3	46858231	1809684	1866688		NC_000003.12:46858230:C:T
NM_000258.3(MYL3):c.*6G>A	MYL3		Cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000925813	3	46899728	3	46858238	925813	909648	rs754568155	NC_000003.12:46858237:C:T
NM_000258.3(MYL3):c.579del (p.Met193fs)	MYL3	M193fs	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 1, 2022)	criteria provided, single submitter	VCV001983370	3	46899743	3	46858253	1983370	2046430		NC_000003.12:46858252:C:
NM_000258.3(MYL3):c.579G>A (p.Met193Ile)	MYL3	M193I	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000952927	3	46899743	3	46858253	952927	923219	rs1701951962	NC_000003.12:46858252:C:T
NM_000258.3(MYL3):c.577A>G (p.Met193Val)	MYL3	M193V	Cardiomyopathy	Uncertain significance(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000925117	3	46899745	3	46858255	925117	909651	rs1701951996	NC_000003.12:46858254:T:C
NM_000258.3(MYL3):c.575dup (p.Met193fs)	MYL3	M193fs	Cardiovascular phenotype|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV001004078	3	46899746 - 46899747	3	46858256 - 46858257	1004078	989606	rs757730888	NC_000003.12:46858256:A:AA
NM_000258.3(MYL3):c.575T>A (p.Ile192Asn)	MYL3	I129N, I134N, I192N	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 3, 2022)	criteria provided, single submitter	VCV002105706	3	46899747	3	46858257	2105706	2166167		NC_000003.12:46858256:A:T
NM_000258.3(MYL3):c.571C>G (p.His191Asp)	MYL3	H191D	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000222738	3	46899751	3	46858261	222738	224280	rs869025487	NC_000003.12:46858260:G:C
NM_000258.3(MYL3):c.568A>G (p.Lys190Glu)	MYL3	K190E	Hypertrophic cardiomyopathy|not provided	Uncertain significance(Last reviewed: Sep 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV001311228	3	46899754	3	46858264	1311228	1300609		NC_000003.12:46858263:T:C
NM_000258.3(MYL3):c.560-1G>C	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001408378	3	46899763	3	46858273	1408378	1422025		NC_000003.12:46858272:C:G
NM_000258.3(MYL3):c.560-1G>A	MYL3		Cardiomyopathy	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000920752	3	46899763	3	46858273	920752	915371	rs1701953138	NC_000003.12:46858272:C:T
NM_000258.3(MYL3):c.560-2del	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000454400	3	46899764	3	46858274	454400	452438	rs1553639782	NC_000003.12:46858273:T:
NM_000258.3(MYL3):c.560-3C>T	MYL3		Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 26, 2015)	criteria provided, single submitter	VCV000222739	3	46899765	3	46858275	222739	224281	rs869025488	NC_000003.12:46858274:G:A
NM_000258.3(MYL3):c.559+2T>C	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 16, 2022)	criteria provided, single submitter	VCV002017667	3	46899872	3	46858382	2017667	2065308		NC_000003.12:46858381:A:G
NM_000258.3(MYL3):c.557A>C (p.Glu186Ala)	MYL3	E186A	Hypertrophic cardiomyopathy 8|Cardiomyopathy	Uncertain significance(Last reviewed: Sep 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV001172131	3	46899876	3	46858386	1172131	1160510		NC_000003.12:46858385:T:G
NM_000258.3(MYL3):c.553T>A (p.Tyr185Asn)	MYL3	Y185N	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV001359700	3	46899880	3	46858390	1359700	1473575		NC_000003.12:46858389:A:T
NM_000258.3(MYL3):c.539A>G (p.Asn180Ser)	MYL3	N180S	Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000650016	3	46899894	3	46858404	650016	631458	rs1575497410	NC_000003.12:46858403:T:C
NM_000258.3(MYL3):c.536C>T (p.Ser179Phe)	MYL3	S179F	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2022)	criteria provided, single submitter	VCV001368928	3	46899897	3	46858407	1368928	1417818		NC_000003.12:46858406:G:A
NM_000258.3(MYL3):c.536C>A (p.Ser179Tyr)	MYL3	S179Y	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV001036975	3	46899897	3	46858407	1036975	1025316	rs1701955175	NC_000003.12:46858406:G:T
NM_000258.3(MYL3):c.530A>G (p.Glu177Gly)	MYL3	E177G	Cardiovascular phenotype|not specified|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000036648	3	46899903	3	46858413	36648	45310	rs193922391	NC_000003.12:46858412:T:C
NM_000258.3(MYL3):c.521C>T (p.Ala174Val)	MYL3	A174V	Cardiomyopathy	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000629442	3	46899912	3	46858422	629442	616927	rs763216044	NC_000003.12:46858421:G:A
NM_000258.3(MYL3):c.520G>C (p.Ala174Pro)	MYL3	A174P	not specified|Cardiomyopathy	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043127	3	46899913	3	46858423	43127	52297	rs397516279	NC_000003.12:46858422:C:G
NM_000258.3(MYL3):c.518T>C (p.Met173Thr)	MYL3	M173T	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Nov 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000580400	3	46899915	3	46858425	580400	559521	rs730880962	NC_000003.12:46858424:A:G
NM_000258.3(MYL3):c.517A>G (p.Met173Val)	MYL3	M173V	Cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031779	3	46899916	3	46858426	31779	40439	rs199474708	NC_000003.12:46858425:T:C
NM_000258.3(MYL3):c.508G>C (p.Glu170Gln)	MYL3	E170Q	Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000970425	3	46899925	3	46858435	970425	953496	rs864622538	NC_000003.12:46858434:C:G
NM_000258.3(MYL3):c.508G>A (p.Glu170Lys)	MYL3	E170K	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 28, 2022)	criteria provided, single submitter	VCV000220466	3	46899925	3	46858435	220466	221419	rs864622538	NC_000003.12:46858434:C:T
NM_000258.3(MYL3):c.505G>A (p.Val169Met)	MYL3	V106M, V169M, V111M	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 16, 2022)	criteria provided, single submitter	VCV002110716	3	46899928	3	46858438	2110716	2171179		NC_000003.12:46858437:C:T
NM_000258.3(MYL3):c.505G>C (p.Val169Leu)	MYL3	V111L, V106L, V169L	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 22, 2022)	criteria provided, single submitter	VCV002087168	3	46899928	3	46858438	2087168	2137229		NC_000003.12:46858437:C:G
NM_000258.3(MYL3):c.503A>C (p.Glu168Ala)	MYL3	E110A, E168A, E105A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 5, 2022)	criteria provided, single submitter	VCV002107027	3	46899930	3	46858440	2107027	2170081		NC_000003.12:46858439:T:G
NM_000258.3(MYL3):c.502G>A (p.Glu168Lys)	MYL3	E168K	Cardiomyopathy	Uncertain significance(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000918792	3	46899931	3	46858441	918792	909655	rs1376871183	NC_000003.12:46858440:C:T
NM_000258.3(MYL3):c.499G>A (p.Asp167Asn)	MYL3	D167N	Cardiovascular phenotype|Cardiomyopathy	Uncertain significance(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000919850	3	46899934	3	46858444	919850	909656	rs1701956074	NC_000003.12:46858443:C:T
NM_000258.3(MYL3):c.494C>G (p.Thr165Arg)	MYL3	T165R	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 1, 2022)	criteria provided, single submitter	VCV001022551	3	46899939	3	46858449	1022551	1004788	rs1701956180	NC_000003.12:46858448:G:C
NM_000258.3(MYL3):c.488G>A (p.Arg163Lys)	MYL3	R163K	Cardiomyopathy	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000922074	3	46899945	3	46858455	922074	909657	rs752165383	NC_000003.12:46858454:C:T
NM_000258.3(MYL3):c.487A>G (p.Arg163Gly)	MYL3	R163G	Cardiovascular phenotype|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001367821	3	46899946	3	46858456	1367821	1401671		NC_000003.12:46858455:T:C
NM_000258.3(MYL3):c.486G>C (p.Glu162Asp)	MYL3	E104D, E162D	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 19, 2022)	criteria provided, single submitter	VCV002145539	3	46899947	3	46858457	2145539	1880026		NC_000003.12:46858456:C:G
NM_000258.3(MYL3):c.484G>A (p.Glu162Lys)	MYL3	E162K	Cardiomyopathy	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000922164	3	46899949	3	46858459	922164	909658	rs371642547	NC_000003.12:46858458:C:T
NM_000258.3(MYL3):c.482G>A (p.Gly161Asp)	MYL3	G161D	not specified	Uncertain significance(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000373241	3	46899951	3	46858461	373241	359532	rs1057518300	NC_000003.12:46858460:C:T
NM_000258.3(MYL3):c.482-1G>A	MYL3		not specified	Uncertain significance(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	VCV000164486	3	46899952	3	46858462	164486	173938	rs727503300	NC_000003.12:46858461:C:T
NM_000258.3(MYL3):c.482-6T>C	MYL3		Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000180443	3	46899957	3	46858467	180443	178528	rs730880163	NC_000003.12:46858466:A:G
NM_000258.3(MYL3):c.482-9T>A	MYL3		Cardiomyopathy	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000629340	3	46899960	3	46858470	629340	619193	rs1559519895	NC_000003.12:46858469:A:T
NM_000258.3(MYL3):c.481+5G>A	MYL3		Cardiovascular phenotype|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000571443	3	46900960	3	46859470	571443	561600	rs1005891266	NC_000003.12:46859469:C:T
NM_000258.3(MYL3):c.481G>A (p.Gly161Ser)	MYL3	G103S, E103K, G161S	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 19, 2022)	criteria provided, single submitter	VCV002135285	3	46900965	3	46859475	2135285	2190693		NC_000003.12:46859474:C:T
NM_000258.3(MYL3):c.481G>T (p.Gly161Cys)	MYL3	G161C	Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000585287	3	46900965	3	46859475	585287	576329	rs1356433667	NC_000003.12:46859474:C:A
NM_000258.3(MYL3):c.476C>T (p.Thr159Met)	MYL3	T159M	Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy	Uncertain significance(Last reviewed: Sep 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000918948	3	46900970	3	46859480	918948	909660	rs748832105	NC_000003.12:46859479:G:A
NM_000258.3(MYL3):c.475A>T (p.Thr159Ser)	MYL3	T101S, T159S	Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV001742880	3	46900971	3	46859481	1742880	1808961		NC_000003.12:46859480:T:A
NM_000258.3(MYL3):c.466G>C (p.Val156Leu)	MYL3	V156L	Hypertrophic cardiomyopathy|Restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000848489	3	46900980	3	46859490	848489	828189	rs199474707	NC_000003.12:46859489:C:G
NM_000258.3(MYL3):c.464A>T (p.His155Leu)	MYL3	H97L, H155L	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, single submitter	VCV002044976	3	46900982	3	46859492	2044976	2092549		NC_000003.12:46859491:T:A
NM_000258.3(MYL3):c.461G>A (p.Arg154His)	MYL3	R154H	Cardiovascular phenotype|Cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000014062	3	46900985	3	46859495	14062	29101	rs104893749	NC_000003.12:46859494:C:T
NM_000258.3(MYL3):c.460C>T (p.Arg154Cys)	MYL3	R154C	Cardiovascular phenotype|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043124	3	46900986	3	46859496	43124	52294	rs143852164	NC_000003.12:46859495:G:A
NM_000258.3(MYL3):c.454_458delinsCTCACTCGACCTTCTCACTTCTCCATAGGTGTCAGCGCCTACCACCAGGGGGCCTGGCAAATCAGCATGGATCCAGATGCTCCAGCAAACCATTACTGCATGTCACCACG (p.Glu152_Leu153delinsLeuThrArgProSerHisPheSerIleGlyValSerAlaTyrHisGlnGlyAlaTrpGlnIleSerMetAspProAspAlaProAlaAsnHisTyrCysMetSerProArg)	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 14, 2022)	criteria provided, single submitter	VCV001994344	3	46900988 - 46900992	3	46859498 - 46859502	1994344	2056144		
NM_000258.3(MYL3):c.456G>T (p.Glu152Asp)	MYL3	E152D	Cardiovascular phenotype|not provided	Uncertain significance(Last reviewed: Mar 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV001189638	3	46900990	3	46859500	1189638	1179725		NC_000003.12:46859499:C:A
NM_000258.3(MYL3):c.452C>T (p.Ala151Val)	MYL3	A151V	Hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228934	3	46900994	3	46859504	228934	229097	rs876657895	NC_000003.12:46859503:G:A
NM_000258.3(MYL3):c.449G>A (p.Gly150Asp)	MYL3	G150D	not provided|Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Jul 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000426252	3	46900997	3	46859507	426252	414942	rs1085307526	NC_000003.12:46859506:C:T
NM_000258.3(MYL3):c.447G>A (p.Met149Ile)	MYL3	M149I	Cardiovascular phenotype	Uncertain significance(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV000180442	3	46900999	3	46859509	180442	178529	rs730880162	NC_000003.12:46859508:C:T
NM_000258.3(MYL3):c.435T>A (p.Asn145Lys)	MYL3	N145K	not specified	Uncertain significance(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000373710	3	46901011	3	46859521	373710	359471	rs774762882	NC_000003.12:46859520:A:T
NM_000258.3(MYL3):c.434A>C (p.Asn145Thr)	MYL3	N145T, N87T	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 11, 2022)	criteria provided, single submitter	VCV001963067	3	46901012	3	46859522	1963067	2020618		NC_000003.12:46859521:T:G
NM_000258.3(MYL3):c.433A>G (p.Asn145Asp)	MYL3	N145D	not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV001051693	3	46901013	3	46859523	1051693	1042261		NC_000003.12:46859522:T:C
NM_000258.3(MYL3):c.424A>G (p.Lys142Glu)	MYL3	K142E	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV000454399	3	46901022	3	46859532	454399	452743	rs1553639863	NC_000003.12:46859531:T:C
NM_000258.3(MYL3):c.421G>A (p.Asp141Asn)	MYL3	D141N	Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV001284346	3	46901025	3	46859535	1284346	1274200		NC_000003.12:46859534:C:T
NM_000258.3(MYL3):c.421G>T (p.Asp141Tyr)	MYL3	D141Y	Cardiomyopathy	Uncertain significance(Last reviewed: Jan 5, 2021)	criteria provided, single submitter	VCV001171264	3	46901025	3	46859535	1171264	1160513		NC_000003.12:46859534:C:A
NM_000258.3(MYL3):c.419T>C (p.Phe140Ser)	MYL3	F140S, F82S	Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 5, 2022)	criteria provided, single submitter	VCV001738631	3	46901027	3	46859537	1738631	1790964		NC_000003.12:46859536:A:G
NM_000258.3(MYL3):c.419T>G (p.Phe140Cys)	MYL3	F140C	Cardiomyopathy	Uncertain significance(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000626471	3	46901027	3	46859537	626471	614897	rs1559520147	NC_000003.12:46859536:A:C
NM_000258.3(MYL3):c.413G>A (p.Arg138Gln)	MYL3	R138Q	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy	Uncertain significance(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000392833	3	46901033	3	46859543	392833	367627	rs1057524652	NC_000003.12:46859542:C:T
NM_000258.3(MYL3):c.412C>T (p.Arg138Trp)	MYL3	R138W	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 12, 2022)	criteria provided, single submitter	VCV000454398	3	46901034	3	46859544	454398	452439	rs1471322504	NC_000003.12:46859543:G:A
NM_000258.3(MYL3):c.410dup (p.Arg138fs)	MYL3	R138fs	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000582720	3	46901035 - 46901036	3	46859545 - 46859546	582720	562972	rs745346844	NC_000003.12:46859545:A:AA
NM_000258.3(MYL3):c.401_405dup (p.Gly136fs)	MYL3	G136fs	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000935720	3	46901040 - 46901041	3	46859550 - 46859551	935720	931964	rs1701967931	NC_000003.12:46859550:CTCCAC:CTCCACTCCAC
NM_000258.3(MYL3):c.400G>A (p.Val134Met)	MYL3	V134M	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000264162	3	46901046	3	46859556	264162	258323	rs776163180	NC_000003.12:46859555:C:T
NM_000258.3(MYL3):c.397T>A (p.Phe133Ile)	MYL3	F133I	not provided	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000495783	3	46901049	3	46859559	495783	487035	rs1553639870	NC_000003.12:46859558:A:T
NM_000258.3(MYL3):c.392A>G (p.Glu131Gly)	MYL3	E131G	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 22, 2022)	criteria provided, single submitter	VCV001391345	3	46901054	3	46859564	1391345	1390025		NC_000003.12:46859563:T:C
NM_000258.3(MYL3):c.383G>C (p.Gly128Ala)	MYL3	G128A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001521266	3	46901063	3	46859573	1521266	1446919		NC_000003.12:46859572:C:G
NM_000258.3(MYL3):c.380C>G (p.Thr127Arg)	MYL3	T127R	not provided	Uncertain significance(Last reviewed: Aug 3, 2013)	criteria provided, single submitter	VCV000181443	3	46901066	3	46859576	181443	179058	rs730880958	NC_000003.12:46859575:G:C
NM_000258.3(MYL3):c.370A>T (p.Asn124Tyr)	MYL3	N124Y	Cardiovascular phenotype|Cardiomyopathy	Uncertain significance(Last reviewed: Dec 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000927180	3	46901076	3	46859586	927180	909663	rs1278498849	NC_000003.12:46859585:T:A
NM_000258.3(MYL3):c.365C>T (p.Ser122Phe)	MYL3	S122F, S64F	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 22, 2022)	criteria provided, single submitter	VCV001713377	3	46901081	3	46859591	1713377	1777272		NC_000003.12:46859590:G:A
NM_000258.3(MYL3):c.358C>T (p.His120Tyr)	MYL3	H120Y	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001004366	3	46901088	3	46859598	1004366	989607	rs1701968794	NC_000003.12:46859597:G:A
NM_000258.3(MYL3):c.350T>C (p.Met117Thr)	MYL3	M117T	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 4, 2022)	criteria provided, single submitter	VCV001370289	3	46901096	3	46859606	1370289	1352628		NC_000003.12:46859605:A:G
NM_000258.3(MYL3):c.349A>G (p.Met117Val)	MYL3	M117V	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000842809	3	46901097	3	46859607	842809	828190	rs1701968895	NC_000003.12:46859606:T:C
NM_000258.3(MYL3):c.347C>T (p.Pro116Leu)	MYL3	P116L	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV000568126	3	46901099	3	46859609	568126	559006	rs777888933	NC_000003.12:46859608:G:A
NM_000258.3(MYL3):c.338C>T (p.Thr113Ile)	MYL3	T113I	not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043122	3	46901108	3	46859618	43122	52292	rs397516278	NC_000003.12:46859617:G:A
NM_000258.3(MYL3):c.337A>G (p.Thr113Ala)	MYL3	T113A, T55A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 6, 2022)	criteria provided, single submitter	VCV002149018	3	46901109	3	46859619	2149018	1877466		NC_000003.12:46859618:T:C
NM_000258.3(MYL3):c.326T>C (p.Met109Thr)	MYL3	M109T	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 15, 2022)	criteria provided, single submitter	VCV001433927	3	46901120	3	46859630	1433927	1497625		NC_000003.12:46859629:A:G
NM_000258.3(MYL3):c.320A>G (p.Lys107Arg)	MYL3	K107R	Cardiomyopathy	Uncertain significance(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000924491	3	46901126	3	46859636	924491	909665	rs1701969420	NC_000003.12:46859635:T:C
NM_000258.3(MYL3):c.317C>T (p.Thr106Ile)	MYL3	T106I, T48I	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2022)	criteria provided, single submitter	VCV001962703	3	46901129	3	46859639	1962703	2010350		NC_000003.12:46859638:G:A
NM_000258.3(MYL3):c.308-3C>T	MYL3		Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV001011968	3	46901141	3	46859651	1011968	989608	rs112911997	NC_000003.12:46859650:G:A
NM_000258.3(MYL3):c.308-17G>T	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 3, 2022)	criteria provided, single submitter	VCV002067453	3	46901155	3	46859665	2067453	2118846		NC_000003.12:46859664:C:A
NM_000258.3(MYL3):c.307+4G>C	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 14, 2022)	criteria provided, single submitter	VCV002156134	3	46902162	3	46860672	2156134	1889733		NC_000003.12:46860671:C:G
NM_000258.3(MYL3):c.307+3A>G	MYL3		Cardiomyopathy	Uncertain significance(Last reviewed: Mar 16, 2021)	criteria provided, single submitter	VCV001332485	3	46902163	3	46860673	1332485	1323203		NC_000003.12:46860672:T:C
NM_000258.3(MYL3):c.307G>A (p.Glu103Lys)	MYL3	E103K	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001414751	3	46902166	3	46860676	1414751	1369953		NC_000003.12:46860675:C:T
NM_000258.3(MYL3):c.301C>G (p.Gln101Glu)	MYL3	Q101E	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 25, 2021)	criteria provided, single submitter	VCV000237446	3	46902172	3	46860682	237446	239237	rs747691982	NC_000003.12:46860681:G:C
NM_000258.3(MYL3):c.296C>G (p.Pro99Arg)	MYL3	P99R	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Dec 10, 2021)	criteria provided, single submitter	VCV001396749	3	46902177	3	46860687	1396749	1414624		NC_000003.12:46860686:G:C
NM_000258.3(MYL3):c.295C>G (p.Pro99Ala)	MYL3	P99A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001004847	3	46902178	3	46860688	1004847	989609	rs1701982094	NC_000003.12:46860687:G:C
NM_000258.3(MYL3):c.294G>T (p.Lys98Asn)	MYL3	K98N	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2022)	criteria provided, single submitter	VCV001437072	3	46902179	3	46860689	1437072	1435642		NC_000003.12:46860688:C:A
NM_000258.3(MYL3):c.292A>G (p.Lys98Glu)	MYL3	K98E	Hypertrophic cardiomyopathy|not provided	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181442	3	46902181	3	46860691	181442	179059	rs730880957	NC_000003.12:46860690:T:C
NM_000258.3(MYL3):c.283G>T (p.Val95Phe)	MYL3	V95F	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000524976	3	46902190	3	46860700	524976	519501	rs1553639921	NC_000003.12:46860699:C:A
NM_000258.3(MYL3):c.281G>C (p.Arg94Pro)	MYL3	R36P, R94P	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 10, 2022)	criteria provided, single submitter	VCV002058934	3	46902192	3	46860702	2058934	2106460		NC_000003.12:46860701:C:G
NM_000258.3(MYL3):c.280C>A (p.Arg94Ser)	MYL3	R94S	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV000409236	3	46902193	3	46860703	409236	393836	rs730880961	NC_000003.12:46860702:G:T
NM_000258.3(MYL3):c.280C>T (p.Arg94Cys)	MYL3	R94C	Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 8, 2023)	criteria provided, multiple submitters, no conflicts	VCV000181448	3	46902193	3	46860703	181448	179060	rs730880961	NC_000003.12:46860702:G:A
NM_000258.3(MYL3):c.278T>C (p.Leu93Pro)	MYL3	L35P, L93P	Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV001796032	3	46902195	3	46860705	1796032	1853391		NC_000003.12:46860704:A:G
NM_000258.3(MYL3):c.274G>A (p.Val92Met)	MYL3	V92M	Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000626717	3	46902199	3	46860709	626717	614898	rs770961856	NC_000003.12:46860708:C:T
NM_000258.3(MYL3):c.265C>T (p.Gln89Ter)	MYL3	Q89*	Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000952172	3	46902208	3	46860718	952172	923220	rs1701982801	NC_000003.12:46860717:G:A
NM_000258.3(MYL3):c.263C>T (p.Thr88Ile)	MYL3	T88I, T30I	Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001794172	3	46902210	3	46860720	1794172	1842452		NC_000003.12:46860719:G:A
NM_000258.3(MYL3):c.256A>T (p.Asn86Tyr)	MYL3	N86Y	Hypertrophic cardiomyopathy|not provided	Uncertain significance(Last reviewed: Mar 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV001040647	3	46902217	3	46860727	1040647	1025317	rs1257328187	NC_000003.12:46860726:T:A
NM_000258.3(MYL3):c.251G>C (p.Gly84Ala)	MYL3	G84A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001498202	3	46902222	3	46860732	1498202	1372842		NC_000003.12:46860731:C:G
NM_000258.3(MYL3):c.245C>T (p.Ala82Val)	MYL3	A82V	Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not specified	Uncertain significance(Last reviewed: Jun 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000568020	3	46902228	3	46860738	568020	561602	rs752549068	NC_000003.12:46860737:G:A
NM_000258.3(MYL3):c.244G>T (p.Ala82Ser)	MYL3	A24S, A82S	Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 8, 2022)	criteria provided, single submitter	VCV001791471	3	46902229	3	46860739	1791471	1848290		NC_000003.12:46860738:C:A
NM_000258.3(MYL3):c.241C>T (p.Arg81Trp)	MYL3	R81W	Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Oct 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000952795	3	46902232	3	46860742	952795	923221	rs761891361	NC_000003.12:46860741:G:A
NM_000258.3(MYL3):c.235G>A (p.Val79Ile)	MYL3	V79I	Cardiovascular phenotype|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 14, 2023)	criteria provided, multiple submitters, no conflicts	VCV000161329	3	46902238	3	46860748	161329	171084	rs150634297	NC_000003.12:46860747:C:T
NM_000258.3(MYL3):c.229G>A (p.Gly77Arg)	MYL3	G77R	Cardiomyopathy	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000629011	3	46902244	3	46860754	629011	616931	rs1559520411	NC_000003.12:46860753:C:T
NM_000258.3(MYL3):c.227G>A (p.Cys76Tyr)	MYL3	C76Y	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 10, 2022)	criteria provided, single submitter	VCV001046319	3	46902246	3	46860756	1046319	1025318	rs370857205	NC_000003.12:46860755:C:T
NM_000258.3(MYL3):c.218A>G (p.Tyr73Cys)	MYL3	Y73C	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000965985	3	46902255	3	46860765	965985	953497	rs1701983870	NC_000003.12:46860764:T:C
NM_000258.3(MYL3):c.211A>T (p.Ile71Phe)	MYL3	I13F, I71F	not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jul 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV001786217	3	46902262	3	46860772	1786217	1846969		NC_000003.12:46860771:T:A
NM_000258.3(MYL3):c.206T>A (p.Met69Lys)	MYL3	M69K	Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Feb 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000650368	3	46902267	3	46860777	650368	631459	rs1575498236	NC_000003.12:46860776:A:T
NM_000258.3(MYL3):c.200G>A (p.Cys67Tyr)	MYL3	C67Y, C9Y	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 5, 2022)	criteria provided, single submitter	VCV002099271	3	46902273	3	46860783	2099271	2150592		NC_000003.12:46860782:C:T
NM_000258.3(MYL3):c.194C>G (p.Pro65Arg)	MYL3	P65R	Cardiovascular phenotype|not provided	Uncertain significance(Last reviewed: Jul 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000181440	3	46902279	3	46860789	181440	179062	rs730880955	NC_000003.12:46860788:G:C
NM_000258.3(MYL3):c.193C>G (p.Pro65Ala)	MYL3	P65A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001359828	3	46902280	3	46860790	1359828	1473702		NC_000003.12:46860789:G:C
NM_000258.3(MYL3):c.191C>T (p.Thr64Ile)	MYL3	T64I	not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000636485	3	46902282	3	46860792	636485	624268	rs1575498249	NC_000003.12:46860791:G:A
NM_000258.3(MYL3):c.188G>A (p.Arg63His)	MYL3	R63H	Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000626718	3	46902285	3	46860795	626718	614899	rs139354105	NC_000003.12:46860794:C:T
NM_000258.3(MYL3):c.188G>C (p.Arg63Pro)	MYL3	R63P	Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000181439	3	46902285	3	46860795	181439	179064	rs139354105	NC_000003.12:46860794:C:G
NM_000258.3(MYL3):c.187C>T (p.Arg63Cys)	MYL3	R63C	Cardiovascular phenotype|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000177931	3	46902286	3	46860796	177931	173799	rs565312070	NC_000003.12:46860795:G:A
NM_000258.3(MYL3):c.184G>A (p.Asp62Asn)	MYL3	D62N	not provided|Cardiomyopathy|not specified	Uncertain significance(Last reviewed: Apr 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000181438	3	46902289	3	46860799	181438	179065	rs730880954	NC_000003.12:46860798:C:T
NM_000258.3(MYL3):c.178C>G (p.Leu60Val)	MYL3	L60V	Cardiomyopathy	Uncertain significance(Last reviewed: Jul 7, 2021)	criteria provided, single submitter	VCV000923689	3	46902295	3	46860805	923689	909667	rs1367233580	NC_000003.12:46860804:G:C
NM_000258.3(MYL3):c.175A>G (p.Met59Val)	MYL3	M1V, M59V	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 8, 2022)	criteria provided, single submitter	VCV002135346	3	46902298	3	46860808	2135346	2188601		NC_000003.12:46860807:T:C
NM_000258.3(MYL3):c.175A>T (p.Met59Leu)	MYL3	M59L	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 26, 2022)	criteria provided, single submitter	VCV001378960	3	46902298	3	46860808	1378960	1408151		NC_000003.12:46860807:T:A
NM_000258.3(MYL3):c.170C>T (p.Ala57Val)	MYL3	A57V	Cardiovascular phenotype|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Oct 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000639935	3	46902303	3	46860813	639935	631460	rs139794067	NC_000003.12:46860812:G:A
NM_000258.3(MYL3):c.158-2A>G	MYL3		Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV001402380	3	46902317	3	46860827	1402380	1466507		NC_000003.12:46860826:T:C
NM_000258.3(MYL3):c.158-3C>A	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 7, 2022)	criteria provided, single submitter	VCV001999748	3	46902318	3	46860828	1999748	2054241		NC_000003.12:46860827:G:T
NM_000258.3(MYL3):c.158-3C>G	MYL3		Hypertrophic cardiomyopathy 8|Cardiomyopathy	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000926233	3	46902318	3	46860828	926233	915373	rs111668273	NC_000003.12:46860827:G:C
NM_000258.3(MYL3):c.157+6del	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001489494	3	46902444	3	46860954	1489494	1495100		NC_000003.12:46860953:G:
NM_000258.3(MYL3):c.154G>A (p.Glu52Lys)	MYL3	E52K	not provided	Uncertain significance(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001313572	3	46902453	3	46860963	1313572	1303833		NC_000003.12:46860962:C:T
NM_000258.3(MYL3):c.152T>C (p.Ile51Thr)	MYL3	I51T	Cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000426762	3	46902455	3	46860965	426762	414943	rs749017586	NC_000003.12:46860964:A:G
NM_000258.3(MYL3):c.147G>T (p.Glu49Asp)	MYL3	E49D	Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000659460	3	46902460	3	46860970	659460	631461	rs1004231349	NC_000003.12:46860969:C:A
NM_000258.3(MYL3):c.142C>G (p.Pro48Ala)	MYL3	P48A	not provided	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV001307258	3	46902465	3	46860975	1307258	1298528		NC_000003.12:46860974:G:C
NM_000258.3(MYL3):c.140C>T (p.Thr47Ile)	MYL3	T47I	Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV001171489	3	46902467	3	46860977	1171489	1160515		NC_000003.12:46860976:G:A
NM_000258.3(MYL3):c.136T>C (p.Phe46Leu)	MYL3	F46L	Hypertrophic cardiomyopathy|not provided|Cardiomyopathy|Cardiovascular phenotype|not specified	Uncertain significance(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181437	3	46902471	3	46860981	181437	179066	rs730880953	NC_000003.12:46860980:A:G
NM_000258.3(MYL3):c.133G>C (p.Glu45Gln)	MYL3	E45Q	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV000966115	3	46902474	3	46860984	966115	953498	rs1701987196	NC_000003.12:46860983:C:G
NM_000258.3(MYL3):c.130-1G>A	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001025213	3	46902478	3	46860988	1025213	1004789	rs1701987231	NC_000003.12:46860987:C:T
NC_000003.11:g.(?_46904732)_(46904900_?)dup	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584123	3	46904732 - 46904900	3	46863242 - 46863410	584123	561054		
NC_000003.11:g.(?_46904742)_(46904890_?)dup	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000654669	3	46904742 - 46904890	3	46863252 - 46863400	654669	651001		
NM_000258.3(MYL3):c.129+1G>T	MYL3		Cardiomyopathy	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000921187	3	46904751	3	46863261	921187	915375	rs112545893	NC_000003.12:46863260:C:A
NM_000258.3(MYL3):c.127A>G (p.Lys43Glu)	MYL3	K43E	Cardiomyopathy	Uncertain significance(Last reviewed: Jan 19, 2021)	criteria provided, single submitter	VCV001171490	3	46904754	3	46863264	1171490	1160516		NC_000003.12:46863263:T:C
NM_000258.3(MYL3):c.124A>T (p.Ile42Phe)	MYL3	I42F	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 22, 2022)	criteria provided, single submitter	VCV001386679	3	46904757	3	46863267	1386679	1357806		NC_000003.12:46863266:T:A
NM_000258.3(MYL3):c.110T>C (p.Phe37Ser)	MYL3	F37S	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001466609	3	46904771	3	46863281	1466609	1347967		NC_000003.12:46863280:A:G
NM_000258.3(MYL3):c.106G>A (p.Glu36Lys)	MYL3	E36K	Cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000872544	3	46904775	3	46863285	872544	859274	rs749941468	NC_000003.12:46863284:C:T
NM_000258.3(MYL3):c.103G>A (p.Val35Ile)	MYL3	V35I	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 15, 2021)	criteria provided, single submitter	VCV001402256	3	46904778	3	46863288	1402256	1454066		NC_000003.12:46863287:C:T
NM_000258.3(MYL3):c.102G>T (p.Glu34Asp)	MYL3	E34D	not provided	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV001310648	3	46904779	3	46863289	1310648	1301352		NC_000003.12:46863288:C:A
NM_000258.3(MYL3):c.100G>A (p.Glu34Lys)	MYL3	E34K	Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 26, 2022)	criteria provided, single submitter	VCV001797502	3	46904781	3	46863291	1797502	1854420		NC_000003.12:46863290:C:T
NM_000258.3(MYL3):c.91C>A (p.Arg31Ser)	MYL3	R31S	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001474126	3	46904790	3	46863300	1474126	1410658		NC_000003.12:46863299:G:T
NM_000258.3(MYL3):c.91C>T (p.Arg31Cys)	MYL3	R31C	not specified|not provided|Hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043131	3	46904790	3	46863300	43131	52301	rs377026344	NC_000003.12:46863299:G:A
NM_000258.3(MYL3):c.82G>A (p.Glu28Lys)	MYL3	E28K	Hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Oct 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228935	3	46904799	3	46863309	228935	229101	rs754220375	NC_000003.12:46863308:C:T
NM_000258.3(MYL3):c.80C>G (p.Pro27Arg)	MYL3	P27R	Cardiomyopathy	Uncertain significance(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV000921559	3	46904801	3	46863311	921559	909668	rs1210373907	NC_000003.12:46863310:G:C
NM_000258.3(MYL3):c.79C>T (p.Pro27Ser)	MYL3	P27S	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001505954	3	46904802	3	46863312	1505954	1339684		NC_000003.12:46863311:G:A
NM_000258.3(MYL3):c.79C>G (p.Pro27Ala)	MYL3	P27A	Hypertrophic cardiomyopathy 8|Cardiomyopathy	Uncertain significance(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000919393	3	46904802	3	46863312	919393	909669	rs1248338056	NC_000003.12:46863311:G:C
NM_000258.3(MYL3):c.77C>G (p.Pro26Arg)	MYL3	P26R	Cardiomyopathy	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000922411	3	46904804	3	46863314	922411	909670	rs1702011145	NC_000003.12:46863313:G:C
NM_000258.3(MYL3):c.73C>T (p.Pro25Ser)	MYL3	P25S	Cardiovascular phenotype|not provided	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181446	3	46904808	3	46863318	181446	179067	rs369256548	NC_000003.12:46863317:G:A
NM_000258.3(MYL3):c.71C>T (p.Ala24Val)	MYL3	A24V	Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000951125	3	46904810	3	46863320	951125	923222	rs373278317	NC_000003.12:46863319:G:A
NM_000258.3(MYL3):c.70G>A (p.Ala24Thr)	MYL3	A24T	Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903017	3	46904811	3	46863321	903017	889127	rs758048820	NC_000003.12:46863320:C:T
NM_000258.3(MYL3):c.69del (p.Ala24fs)	MYL3	A24fs	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 25, 2022)	criteria provided, single submitter	VCV002116680	3	46904812	3	46863322	2116680	2175763		NC_000003.12:46863321:GGG:GG
NM_000258.3(MYL3):c.65C>T (p.Ala22Val)	MYL3	A22V	Cardiomyopathy	Uncertain significance(Last reviewed: Mar 24, 2021)	criteria provided, single submitter	VCV001332004	3	46904816	3	46863326	1332004	1322724		NC_000003.12:46863325:G:A
NM_000258.3(MYL3):c.61C>T (p.Pro21Ser)	MYL3	P21S	Hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy|Cardiomyopathy	Uncertain significance(Last reviewed: Apr 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000922760	3	46904820	3	46863330	922760	909671	rs779557153	NC_000003.12:46863329:G:A
NM_000258.3(MYL3):c.55G>T (p.Ala19Ser)	MYL3	A19S	Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 20, 2022)	criteria provided, single submitter	VCV001748567	3	46904826	3	46863336	1748567	1806815		NC_000003.12:46863335:C:A
NM_000258.3(MYL3):c.52A>G (p.Lys18Glu)	MYL3	K18E	Cardiomyopathy	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000918521	3	46904829	3	46863339	918521	909672	rs1702011793	NC_000003.12:46863338:T:C
NM_000258.3(MYL3):c.49C>T (p.Pro17Ser)	MYL3	P17S	Cardiovascular phenotype|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000935086	3	46904832	3	46863342	935086	931965	rs1702011848	NC_000003.12:46863341:G:A
NM_000258.3(MYL3):c.47C>T (p.Ala16Val)	MYL3	A16V	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000949150	3	46904834	3	46863344	949150	923223	rs754871327	NC_000003.12:46863343:G:A
NM_000258.3(MYL3):c.40A>C (p.Lys14Gln)	MYL3	K14Q	Cardiomyopathy	Uncertain significance(Last reviewed: Feb 3, 2019)	criteria provided, single submitter	VCV000926245	3	46904841	3	46863351	926245	909673	rs1702011948	NC_000003.12:46863350:T:G
NM_000258.3(MYL3):c.32A>T (p.Asp11Val)	MYL3	D11V	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 6, 2022)	criteria provided, single submitter	VCV001015590	3	46904849	3	46863359	1015590	1004790	rs1227232995	NC_000003.12:46863358:T:A
NM_000258.3(MYL3):c.26A>G (p.Lys9Arg)	MYL3	K9R	not specified|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373705	3	46904855	3	46863365	373705	359533	rs1025864971	NC_000003.12:46863364:T:C
NM_000258.3(MYL3):c.25A>G (p.Lys9Glu)	MYL3	K9E	Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 2, 2022)	criteria provided, single submitter	VCV001793637	3	46904856	3	46863366	1793637	1845762		NC_000003.12:46863365:T:C
NM_000258.3(MYL3):c.17C>G (p.Pro6Arg)	MYL3	P6R	not provided	Uncertain significance(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	VCV000181445	3	46904864	3	46863374	181445	179068	rs730880959	NC_000003.12:46863373:G:C
NM_000258.3(MYL3):c.14A>C (p.Lys5Thr)	MYL3	K5T	Inborn genetic diseases|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV001715451	3	46904867	3	46863377	1715451	1775596		NC_000003.12:46863376:T:G
NM_000258.3(MYL3):c.11A>G (p.Lys4Arg)	MYL3	K4R	Hypertrophic cardiomyopathy|not provided	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000164490	3	46904870	3	46863380	164490	173940	rs727503301	NC_000003.12:46863379:T:C
NM_000258.3(MYL3):c.10A>C (p.Lys4Gln)	MYL3	K4Q	not provided	Uncertain significance	no assertion criteria provided	VCV001297669	3	46904871	3	46863381	1297669	1287457		NC_000003.12:46863380:T:G
NM_000258.3(MYL3):c.8C>A (p.Pro3His)	MYL3	P3H	Cardiovascular phenotype|Cardiomyopathy	Uncertain significance(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000520280	3	46904873	3	46863383	520280	509631	rs536404643	NC_000003.12:46863382:G:T
NM_000258.3(MYL3):c.4G>T (p.Ala2Ser)	MYL3	A2S	Cardiomyopathy	Uncertain significance(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000926689	3	46904877	3	46863387	926689	909678	rs148310342	NC_000003.12:46863386:C:A
NM_000258.3(MYL3):c.2T>A (p.Met1Lys)	MYL3	M1K	Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 9, 2022)	criteria provided, single submitter	VCV001798669	3	46904879	3	46863389	1798669	1855940		NC_000003.12:46863388:A:T
NM_000258.3(MYL3):c.1_2delinsG (p.Met1fs)	MYL3	M1fs	not provided|Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000970431	3	46904879 - 46904880	3	46863389 - 46863390	970431	953499	rs1702012642	NC_000003.12:46863388:AT:C
NM_000258.3(MYL3):c.-15T>A	MYL3		not specified	Uncertain significance(Last reviewed: Aug 6, 2022)	criteria provided, single submitter	VCV001705048	3	46904895	3	46863405	1705048	1699580		NC_000003.12:46863404:A:T
NM_000258.3(MYL3):c.-33T>C	MYL3		Hypertrophic cardiomyopathy 8	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000903018	3	46904913	3	46863423	903018	889128	rs1702013209	NC_000003.12:46863422:A:G
NM_000316.3(PTH1R):c.-166G>A	MYL3|PTH1R		Chondrodysplasia Blomstrand type|Metaphyseal chondrodysplasia, Jansen type	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000345573	3	46919273	3	46877783	345573	294874	rs886058583	NC_000003.12:46877782:G:A
NM_000316.3(PTH1R):c.-64C>A	MYL3|PTH1R		Metaphyseal chondrodysplasia, Jansen type|Chondrodysplasia Blomstrand type	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903019	3	46922593	3	46881103	903019	889129	rs2030528606	NC_000003.12:46881102:C:A
NC_000003.11:g.(?_45435946)_(49137751_?)dup	IP6K2|LZTFL1|MAP4|KLHL18|LARS2|LIMD1|KIF9|LRRC2|LTF|ALS2CL|ARIH2|ARIH2OS|ATRIP|CAMP|CCDC12|CCDC51|CCR1|CCR2|CCR3|CCR5|CCR9|CCRL2|CDC25A|CELSR3|COL7A1|CSPG5|CXCR6|DALRD3|DHX30|ELP6|FBXW12|FYCO1|IMPDH2|MIR191|MYL3|NBEAL2|NCKIPSD|NDUFAF3|NME6|P4HTM|PFKFB4|PLXNB1|PRKAR2A|PRSS50|PTH1R|PTPN23|QARS1|QRICH1|RTP3|SACM1L|SCAP|SETD2|SHISA5|SLC25A20|SLC26A6|SLC6A20|SMARCC1|SPINK8|TDGF1|TMA7|TMEM89|TMIE|TREX1|UCN2|UQCRC1|WDR6|XCR1|ZNF589		Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome	Uncertain significance(Last reviewed: Mar 26, 2022)	criteria provided, single submitter	VCV002425284	3	45435946 - 49137751			2425284	1943012		
NC_000003.11:g.(?_46899734)_(46904880_?)dup	MYL3		Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 6, 2022)	criteria provided, single submitter	VCV002422701	3	46899734 - 46904880			2422701	1939015		
GRCh37/hg19 3p21.31(chr3:46656350-46990919)x3	ALS2CL|CCDC12|MYL3|PRSS50|PTH1R|TMIE		not provided	Uncertain significance(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000814440	3	46656350 - 46990919			814440	802650		
